Comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190 vs 3 4 Toe Syndactyly C1834062
Clinical comparison between 3 Phosphoglycerate Dehydrogenase Deficiency and 3 4 Toe Syndactyly for differential diagnosis and treatment planning.
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
A rare metabolic disorder impairing the body's ability to produce serine, an essential amino acid. It primarily affects the nervous system, causing developmental delay, seizures, and movement difficulties. Management includes serine supplementation and anticonvulsants as needed.
3 4 Toe Syndactyly C1834062
Webbing between the third and fourth toes, a common birth variation. Often requires no treatment as toes usually function normally.
6 comparison axes
Onset
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
0-5
3 4 Toe Syndactyly C1834062
0-0
Onset patterns differ
Severity
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
severe
3 4 Toe Syndactyly C1834062
mild
Different severity levels
Chronic
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
Chronic
3 4 Toe Syndactyly C1834062
Chronic
Differing course
Communicable
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
No
3 4 Toe Syndactyly C1834062
No
Different transmission
Body System
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3 4 Toe Syndactyly C1834062
musculoskeletal
Same/different system
Category
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3 4 Toe Syndactyly C1834062
genetic
Different category
Bottom line
3-phosphoglycerate-dehydrogenase-deficiency-C0580190 and 3-4-toe-syndactyly-C1834062 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3 4 Toe Syndactyly C1834062 | Discriminating power |
|---|---|---|---|
| Neurologic development | Developmental delay, seizures, or movement difficulty may occur. | No neurologic abnormality is implied by isolated toe webbing. | High |
| Foot appearance | Toe webbing is not a described feature. | Skin webbing joins the third and fourth toes from birth. | High |
| Functional impact | Can cause substantial neurologic impairment. | Toes usually function normally and treatment is often unnecessary. | Moderate |
When to favor each condition
Choose 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 when
Infant or young child with seizures and developmental delay
These features fit the described neurologic metabolic disorder, not isolated syndactyly.
Moderate
Suspected disorder of serine production
The left concept specifically concerns impaired serine synthesis.
High
Need for metabolic and neurologic evaluation
Source management may include serine supplementation and anticonvulsants when clinically indicated.
Moderate
Choose 3 4 Toe Syndactyly C1834062 when
Isolated webbing between the third and fourth toes
This is the defining congenital musculoskeletal finding.
High
Normal toe function without neurologic concerns
The supplied description says function is usually normal and treatment often unnecessary.
Moderate
Birth variation without systemic illness
It is described as a common congenital variation rather than a metabolic disease.
Moderate
How key tests differ
| Test | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3 4 Toe Syndactyly C1834062 | Interpretation |
|---|---|---|---|
| Clinical examination | Neurologic findings may be present; exact features vary. | Visible third-to-fourth toe webbing, often with normal function. | Examination separates a systemic neurologic condition from a localized foot variation. |
| Amino acid studies | Serine-related biochemical abnormality may be sought; cutoffs are not supplied. | No amino acid abnormality is expected from isolated syndactyly. | Abnormal results require specialist interpretation and do not by themselves establish the diagnosis. |
| Foot imaging | Not specifically indicated by the source description. | May clarify soft-tissue or bony anatomy if surgery is considered. | Imaging assesses anatomy; it does not diagnose the metabolic disorder. |
Prognosis comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
- Outcome
- Potentially serious chronic neurologic course; exact outcomes are not established here.
- Factors
- Age at recognition, seizure control, developmental impact, and response to specialist care.
3 4 Toe Syndactyly C1834062
- Outcome
- Usually favorable, with normal toe function in most described cases.
- Factors
- Whether webbing is isolated and whether function or comfort is affected.
Time frame: Left may present from birth to early childhood; right is present at birth. Both can be long-term.
System involved, severity, associated findings, and individualized clinical management.
Complications comparison
| Complication | Presentation |
|---|---|
| Seizures | Seizures are a described neurologic feature. Not associated with isolated toe webbing. Seizure care is individualized; no treatment dose is established here. |
| Movement difficulty | Movement problems may accompany developmental delay. Toe function is usually preserved. Impact depends on clinical severity and is not uniform. |
| Local foot concern | No specific foot complication is described. Cosmetic concern or rare functional limitation may prompt assessment. Most cases reportedly need no treatment. |
Patient education highlights
- HighDifferent conditions
One is a rare metabolic neurologic disorder; the other is congenital toe webbing. They are not interchangeable diagnoses.
- HighWhen to seek care
Seizures, developmental concerns, or feeding and movement problems need prompt clinician assessment.
- MediumToe webbing
Isolated third-to-fourth toe syndactyly often functions normally and may require no treatment.